Notably, a familial history of breast or ovarian cancer was reported in 95 (49.7%) and 24 (32%) patients (BRCA1 and BRCA2, respectively); conversely, personal history of previous cancer was reported in only three (1.1%) patients. This evidence concerns the gene BRCA2 and cancer.